Abstract
A series of long-chain arylpiperazines bearing a salicylamide fragment were synthesized, and the target compounds were evaluated for atypical antipsychotic activity in apomorphine-induced climbing behavior (D2 antagonism) and 5-HTP-induced head twitches (5-HT2A antagonism) along with catalepsy studies in mice. The physicochemical similarity values of the target compounds with respect to standard drugs, clozapine, ketanserin, and risperidone, were determined using software programs. The test compounds demonstrated good similarity values with respect to the standard drugs. The compounds 3a4 showed maximum atypical antipsychotic like profile.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call